ITMI20030269A1 - Sale di cetilpiridino di un agente antiinfiammatorio - Google Patents

Sale di cetilpiridino di un agente antiinfiammatorio

Info

Publication number
ITMI20030269A1
ITMI20030269A1 IT000269A ITMI20030269A ITMI20030269A1 IT MI20030269 A1 ITMI20030269 A1 IT MI20030269A1 IT 000269 A IT000269 A IT 000269A IT MI20030269 A ITMI20030269 A IT MI20030269A IT MI20030269 A1 ITMI20030269 A1 IT MI20030269A1
Authority
IT
Italy
Prior art keywords
cetylpyridine
salt
inflammatory agent
inflammatory
agent
Prior art date
Application number
IT000269A
Other languages
English (en)
Inventor
Giorgio Pifferi
Original Assignee
Advance Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Holdings Ltd filed Critical Advance Holdings Ltd
Priority to IT000269A priority Critical patent/ITMI20030269A1/it
Priority to EP04710394A priority patent/EP1592657A1/en
Priority to GEAP20048977A priority patent/GEP20064009B/en
Priority to US10/544,224 priority patent/US7250428B2/en
Priority to MXPA05008589A priority patent/MXPA05008589A/es
Priority to AU2004212154A priority patent/AU2004212154A1/en
Priority to CA002511900A priority patent/CA2511900A1/en
Priority to CNB200480003068XA priority patent/CN1318389C/zh
Priority to PL04376362A priority patent/PL376362A1/xx
Priority to EA200501088A priority patent/EA008003B1/ru
Priority to KR1020057013935A priority patent/KR20050101186A/ko
Priority to PCT/EP2004/001412 priority patent/WO2004072017A1/en
Priority to JP2006501845A priority patent/JP2006517565A/ja
Priority to ARP040100444A priority patent/AR043171A1/es
Publication of ITMI20030269A1 publication Critical patent/ITMI20030269A1/it
Priority to IL169312A priority patent/IL169312A/en
Priority to HK06100260.7A priority patent/HK1080449A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/18—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT000269A 2003-02-14 2003-02-14 Sale di cetilpiridino di un agente antiinfiammatorio ITMI20030269A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT000269A ITMI20030269A1 (it) 2003-02-14 2003-02-14 Sale di cetilpiridino di un agente antiinfiammatorio
CNB200480003068XA CN1318389C (zh) 2003-02-14 2004-02-12 抗炎剂的十六烷基吡啶鎓盐以及含有该盐的药物组合物
PL04376362A PL376362A1 (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
US10/544,224 US7250428B2 (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
MXPA05008589A MXPA05008589A (es) 2003-02-14 2004-02-12 Metodo para el tratamiento de cancer de prostata y composicion para dicho tratamiento.
AU2004212154A AU2004212154A1 (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
CA002511900A CA2511900A1 (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
EP04710394A EP1592657A1 (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
GEAP20048977A GEP20064009B (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and armaceutical compositions containing it
EA200501088A EA008003B1 (ru) 2003-02-14 2004-02-12 Цетилпиридиниевая соль противоспалительного средства и фармацевтические композиции, содержащие ее
KR1020057013935A KR20050101186A (ko) 2003-02-14 2004-02-12 항염제인 세틸파이리디늄염 및 이를 함유하는 약학적조성물
PCT/EP2004/001412 WO2004072017A1 (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
JP2006501845A JP2006517565A (ja) 2003-02-14 2004-02-12 抗炎症剤のセチルピリジニウム塩及びそれを含有する薬学的組成物
ARP040100444A AR043171A1 (es) 2003-02-14 2004-02-13 Sal de cetilpiridinio de un agente antiinflamatorio, composiciones farmaceuticas que la contienen y un procedimiento para la preparacion de la sal.
IL169312A IL169312A (en) 2003-02-14 2005-06-21 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
HK06100260.7A HK1080449A1 (zh) 2003-02-14 2006-01-06 抗炎劑的十六烷基吡啶鹽以及含有該鹽的藥物組合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000269A ITMI20030269A1 (it) 2003-02-14 2003-02-14 Sale di cetilpiridino di un agente antiinfiammatorio

Publications (1)

Publication Number Publication Date
ITMI20030269A1 true ITMI20030269A1 (it) 2004-08-15

Family

ID=32866065

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000269A ITMI20030269A1 (it) 2003-02-14 2003-02-14 Sale di cetilpiridino di un agente antiinfiammatorio

Country Status (16)

Country Link
US (1) US7250428B2 (it)
EP (1) EP1592657A1 (it)
JP (1) JP2006517565A (it)
KR (1) KR20050101186A (it)
CN (1) CN1318389C (it)
AR (1) AR043171A1 (it)
AU (1) AU2004212154A1 (it)
CA (1) CA2511900A1 (it)
EA (1) EA008003B1 (it)
GE (1) GEP20064009B (it)
HK (1) HK1080449A1 (it)
IL (1) IL169312A (it)
IT (1) ITMI20030269A1 (it)
MX (1) MXPA05008589A (it)
PL (1) PL376362A1 (it)
WO (1) WO2004072017A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2011009010A1 (en) * 2009-07-15 2011-01-20 University Of Medicine And Dentistry Of New Jersey Novel compounds for inhibiting eef2 kinase activity
KR101666659B1 (ko) * 2014-06-12 2016-10-14 한국생명공학연구원 부틸 피리디늄 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
IT1228242B (it) 1986-11-13 1991-06-05 Ricerfarma Srl Milano Sale del diclofenac con idrossietilpirrolidina e composizioni farmaceutiche che lo contengono
IT1250636B (it) * 1991-07-04 1995-04-21 Ricerche Di Schiena Del Dr Mic Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
ATE268186T1 (de) * 1994-06-06 2004-06-15 Thejmde Trust Biotinverbindungen zum zielen auf tumore und infektionsherde
DE19856101A1 (de) 1998-12-04 2000-06-08 Labtec Gmbh Mundhöhlen-Matrixpflaster
JP2000256186A (ja) 1999-03-05 2000-09-19 Taisho Pharmaceut Co Ltd 咽頭疾患用組成物

Also Published As

Publication number Publication date
AR043171A1 (es) 2005-07-20
EP1592657A1 (en) 2005-11-09
CN1318389C (zh) 2007-05-30
GEP20064009B (en) 2006-12-25
MXPA05008589A (es) 2005-11-04
US7250428B2 (en) 2007-07-31
KR20050101186A (ko) 2005-10-20
EA008003B1 (ru) 2007-02-27
WO2004072017A1 (en) 2004-08-26
PL376362A1 (en) 2005-12-27
IL169312A (en) 2010-05-17
HK1080449A1 (zh) 2006-04-28
US20060142353A1 (en) 2006-06-29
IL169312A0 (en) 2007-07-04
CA2511900A1 (en) 2004-08-26
CN1745061A (zh) 2006-03-08
AU2004212154A1 (en) 2004-08-26
EA200501088A1 (ru) 2005-12-29
JP2006517565A (ja) 2006-07-27

Similar Documents

Publication Publication Date Title
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
NO20054880D0 (no) Azaspiroalkanderivater som inhibitorer av metallproeaser
IS7714A (is) Lyfjasamsetningar úr módafíníl
DE502004003964D1 (de) Metallkomplexe
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
DE602004001404D1 (de) Metallkapselung
DE602004020680D1 (de) Die aktivität von gamma-secretase blockierende malonamidderivate
SE0302207L (sv) Ny metallbandsprodukt
DK1342881T3 (da) Opskummet syrebehandlingsvæske
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
DK1425019T3 (da) Farmaceutisk sammensætning omfattende et androgen
IS8399A (is) Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns
IS2421B (is) Nýir etónógestrel esterar
ITMI20031847A1 (it) Composizione di fluoropolimeri espandibili senza l'impiego di agenti espandenti.
NO20043937L (no) Anvendelse av vitamin D sammensetninger
ATE440859T1 (de) Acylierte nonadepsipeptide vom lysobactin-typ
SE0302395L (sv) Ny metallbandsprodukt
DE602004000627D1 (de) Hautreinigungsmittel
DK1691814T3 (da) Antiinflammatoriske midler
DE112004001618D2 (de) Pharmazeutischer Wirkstoff gegen Tumorerkrankungen
ITMI20030269A1 (it) Sale di cetilpiridino di un agente antiinfiammatorio
ITMI20031313A1 (it) Associazioni di agenti vasoprotettori e formulazioni che li contengono.
SE0302278L (sv) Skyddsvall
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
IS7537A (is) Notkun á nýjum etónógestrel esterum.